Evidence map›Paper›PMID 31770407›Full record

ArticlePloS one2019

Interleukin-38 interacts with destrin/actin-depolymerizing factor in human keratinocytes.

Dominique Talabot-Ayer, Loïc Mermoud, Julia Borowczyk, Justyna Drukala, Michal Wolnicki, Ali Modarressi, Wolf-Henning Boehncke, Nicolo Brembilla, Gaby Palmer

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Cell Intrinsic IL-38 Affects B Cell Differentiation and Antibody Production.International journal of molecular sciences · 2023
    Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Dominique Talabot-AyerDepartment of Pathology-Immunology, University of Geneva School of Medicine, Geneva, Switzerland.
Loïc MermoudDepartment of Pathology-Immunology, University of Geneva School of Medicine, Geneva, Switzerland.
Julia BorowczykDepartment of Pathology-Immunology, University of Geneva School of Medicine, Geneva, Switzerland.
Justyna DrukalaCell Bank, Department of Cell Biology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Cracow, Poland.
Michal WolnickiDepartment of Pediatric Urology, Jagiellonian University Medical College, Cracow, Poland.
Ali ModarressiDepartment of Plastic, Reconstructive and Aesthetic Surgery, University Hospitals of Geneva, University of Geneva School of Medicine, Geneva, Switzerland.
Wolf-Henning BoehnckeDepartment of Pathology-Immunology, University of Geneva School of Medicine, Geneva, Switzerland.
Nicolo BrembillaDepartment of Pathology-Immunology, University of Geneva School of Medicine, Geneva, Switzerland.
Gaby PalmerDepartment of Pathology-Immunology, University of Geneva School of Medicine, Geneva, Switzerland.ORCID 0000-0001-7567-1798
University of Geneva · CHJagiellonian University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interleukin (IL)-38 is a member of the IL-1 family of cytokines, which was proposed to exert anti-inflammatory effects. IL-38 is constitutively expressed in the skin, where keratinocytes are the main producing cells. Little information is currently available concerning IL-38 biology. Here, we investigated the subcellular localization and interaction partners of the IL-38 protein in human keratinocytes. IL-38 expression was reduced in primary keratinocytes grown in monolayer (2D) cultures. We thus used IL-38 overexpressing immortalized normal human keratinocytes (NHK/38) to study this cytokine in cell monolayers. In parallel, differentiation of primary human keratinocytes in an in vitro reconstructed human epidermis (RHE) 3D model allowed us to restore endogenous IL-38 expression. In NHK/38 cells and in RHE, IL-38 was mainly cell-associated, rather than released into culture supernatants. Intracellular IL-38 was preferentially, although not exclusively, cytoplasmic. Similarly, in normal human skin sections, IL-38 was predominantly cytoplasmic in the epidermis and essentially excluded from keratinocyte nuclei. A yeast two-hybrid screen identified destrin/actin-depolymerizing factor (DSTN) as a potential IL-38-interacting molecule. Co-immunoprecipitation and proximity ligation assay confirmed this interaction. We further observed partial co-localization of IL-38 and DSTN in NHK/38 cells. Endogenous IL-38 and DSTN were also co-expressed in all epidermal layers in RHE and in normal human skin. Finally, IL-38 partially co-localized with F-actin in NHK/38 cells, in particular along the cortical actin network and in filopodia. In conclusion, IL-38 is found predominantly in the cytoplasm of human keratinocytes, where it interacts with DSTN. The functional relevance of this interaction remains to be investigated.

Indexed as

Cell Culture TechniquesCells, CulturedDestrinHumansInterleukinsKeratinocytesMicroscopy, FluorescenceProtein BindingSkinTwo-Hybrid System TechniquesDestrinIL-38 protein, humanInterleukins

Identifiers

PMID31770407
PMCPMC6879167
OpenAlexW2990887256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.